Sleep Questionnaire Validation for Down Syndrome
Trial Summary
What is the purpose of this trial?
This will be a prospective validation study of a sample of consecutive pediatric Down syndrome patients who are seen through the weekly Down syndrome clinic at OHSU/Doernbecher's. Questionnaires will be administered to approximately 5 new patients per month. Since this population has a higher prevalence of OSA than the general pediatric population, and OSA is a potentially modifiable determinant of quality of life, validated instruments are critical in assessing disease burden and response to treatment.
Research Team
Derek Lam, MD
Principal Investigator
Oregon Health and Science University
Eligibility Criteria
This trial is for children with Down syndrome aged 2-17 years who visit the Down syndrome clinic at OHSU/Doernbecher's. They must have had a recent sleep study or be scheduled for one, and their caregivers need to read English or Spanish. Kids with tracheostomy, airway narrowing, or severe heart/lung disease needing extra oxygen can't join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Caregivers complete SRBD-PSQ, OSA-18, and PedsQL questionnaires; initial sleep study is conducted
Follow-up Assessment
Second sleep study conducted if needed, and follow-up questionnaires administered
Follow-up
Participants are monitored for safety and effectiveness after initial assessments
Treatment Details
Interventions
- Sleep study
Find a Clinic Near You
Who Is Running the Clinical Trial?
Oregon Health and Science University
Lead Sponsor